Quick Answer
Ovid Therapeutics Inc. reported Net Income of -$17.41 million for fiscal year 2025.
Ovid Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$17.41M | +34.1% |
| 2024 | -$26.43M | +49.5% |
| 2023 | -$52.34M | +3.4% |
| 2022 | -$54.17M | -144.1% |
| 2021 | $122.83M | +251.6% |
| 2020 | -$81.04M | -34.0% |
| 2019 | -$60.46M | -16.3% |
| 2018 | -$51.98M | +19.8% |
| 2017 | -$64.81M | -189.1% |
| 2016 | -$22.41M | -70.3% |
| 2015 | -$13.16M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.16M | +13.2% | -159.6% |
| June 30, 2025 | -$4.68M | -155.0% | +54.2% |
| March 31, 2025 | -$10.23M | +12.5% | +26.9% |
| September 30, 2024 | -$14.01M | -24.5% | -264.4% |
| June 30, 2024 | $8.52M | +168.7% | +172.9% |
| March 31, 2024 | -$11.69M | +12.4% | -3.9% |
| September 30, 2023 | -$11.25M | +6.0% | +9.3% |
| June 30, 2023 | -$12.41M | +14.9% | +7.1% |
- Ovid Therapeutics Inc. showed an increase of +34.1% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, Ovid Therapeutics Inc.’s net income has declined by 32.3% (from -$13.16 million to -$17.41 million).
- The most recent figure is from Ovid Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: